Piao J - Search Results

1

G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.

Zhu K, Deng C, Du P, Liu T, Piao J, Piao Y, Yang M, Chen L. Zhu K, et al. Among authors: piao y, piao j. Reprod Biol Endocrinol. 2022 Mar 11;20(1):50. doi: 10.1186/s12958-022-00921-6. Reprod Biol Endocrinol. 2022. PMID: 35277194 Free PMC article.

2

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z. Lin L, et al. Among authors: piao y, piao j. BMC Cancer. 2013 Jul 31;13:366. doi: 10.1186/1471-2407-13-366. BMC Cancer. 2013. PMID: 23902796 Free PMC article.

3

High expression of DEK predicts poor prognosis of gastric adenocarcinoma.

Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z. Piao J, et al. Among authors: piao y. Diagn Pathol. 2014 Mar 20;9:67. doi: 10.1186/1746-1596-9-67. Diagn Pathol. 2014. PMID: 24650035 Free PMC article.

4

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.

Kong J, Di C, Piao J, Sun J, Han L, Chen L, Yan G, Lin Z. Kong J, et al. Among authors: piao j. Oncotarget. 2016 Apr 12;7(15):19631-42. doi: 10.18632/oncotarget.7779. Oncotarget. 2016. PMID: 26933912 Free PMC article.

5

Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC.

Piao J, Chen L, Quan T, Li L, Quan C, Piao Y, Jin T, Lin Z. Piao J, et al. Among authors: piao y. Oncotarget. 2016 Sep 13;7(37):60169-60180. doi: 10.18632/oncotarget.11109. Oncotarget. 2016. PMID: 27507059 Free PMC article.

6

HBXIP over expression as an independent biomarker for cervical cancer.

Li N, Wang Y, Che S, Yang Y, Piao J, Liu S, Lin Z. Li N, et al. Among authors: piao j. Exp Mol Pathol. 2017 Feb;102(1):133-137. doi: 10.1016/j.yexmp.2017.01.009. Epub 2017 Jan 16. Exp Mol Pathol. 2017. PMID: 28093193

7

Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.

Sun J, Che SL, Piao JJ, Xu M, Chen LY, Lin ZH. Sun J, et al. Among authors: piao jj. Tumour Biol. 2017 Mar;39(3):1010428317695918. doi: 10.1177/1010428317695918. Tumour Biol. 2017. PMID: 28349826 Free article.

8

β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers.

Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z, Chen L. Yang Y, et al. Among authors: piao j. Sci Rep. 2017 Jun 2;7(1):2681. doi: 10.1038/s41598-017-02937-0. Sci Rep. 2017. PMID: 28578385 Free PMC article.

9

HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.

Wang Y, Li N, Che S, Jin T, Piao J, Liu S, Lin Z. Wang Y, et al. Among authors: piao j. Tumour Biol. 2017 Jul;39(7):1010428317709675. doi: 10.1177/1010428317709675. Tumour Biol. 2017. PMID: 28718367 Free article.

10

Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker.

Piao J, Chen L, Jin T, Xu M, Quan C, Lin Z. Piao J, et al. Hum Pathol. 2018 Mar;73:33-40. doi: 10.1016/j.humpath.2017.10.037. Epub 2017 Dec 16. Hum Pathol. 2018. PMID: 29258905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters